300
Participants
Start Date
January 31, 2013
Primary Completion Date
January 31, 2019
Study Completion Date
January 31, 2020
Treatment modification based on molecular response at 3 months
Patients will be treated with imatinib upon diagnosis of CML. Molecular response will be assessed at 3 months of therapy. Based on molecular response imatinib will be continued or changed to another TKI
RECRUITING
Rabin Medical Center, Petah Tikva
Collaborators (1)
Rambam Health Care Campus
OTHER
Wolfson Medical Center
OTHER_GOV
Bnai Zion Medical Center
OTHER_GOV
HaEmek Medical Center, Israel
OTHER
Hadassah Medical Organization
OTHER
Rabin Medical Center
OTHER